Prescriber's Corner

Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma

Suzanne McGettigan, MSN, CRNP, AOCN®

Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania

Author's disclosures of potential conflicts of interest are found at the end of this article.

Suzanne McGettigan, MSN, CRNP, AOCN®, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Boulevard, PCAM 4 West, Philadelphia, PA 19104. E-mail: Suzanne.McGettigan@uphs.upenn.edu


J Adv Pract Oncol 2014;5:211–215 | DOI: 10.6004/jadpro.2014.5.3.6 | © 2014 Harborside Press®


  



For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here
click me